666P First-line Camrelizumab Plus Chemotherapy for Brain Metastases in NSCLC: the CTONG 2003 Randomized Controlled Trial

J-J. Yang, Y. Li,Q. Yu,Q. Bu,L. Lin, F. Ning,G. Wu,G. Lin,A. Zang,S. Ma, C. Zhou,A. Liu, Y. Zhao,C. Wang,Y. Yao, G. Han, J. Zhao, Y. Pan, J. Lv,Y-L. Wu

Annals of Oncology（2024）

Cited 0|Views5

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined